## **Core Concept**
Hyperphenylalaninemia refers to a condition characterized by elevated levels of phenylalanine in the blood. This condition arises due to defects in the metabolic pathway of phenylalanine. The primary enzyme involved in this pathway is responsible for converting phenylalanine into tyrosine.

## **Why the Correct Answer is Right**
The correct answer, **D.**, corresponds to the enzyme phenylalanine hydroxylase. This enzyme catalyzes the conversion of phenylalanine to tyrosine, a reaction that requires tetrahydrobiopterin (BH4) as a cofactor. A defect in phenylalanine hydroxylase leads to the accumulation of phenylalanine, resulting in hyperphenylalaninemia. This condition is a hallmark of phenylketonuria (PKU), a genetic disorder.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to the enzyme directly associated with the conversion of phenylalanine to tyrosine.
- **Option B:** This option is incorrect as it refers to a different enzyme, not directly related to the primary defect causing hyperphenylalaninemia.
- **Option C:** This option is incorrect because, although it might relate to a step in amino acid metabolism, it does not specifically pertain to the conversion of phenylalanine to tyrosine.

## **Clinical Pearl / High-Yield Fact**
A crucial clinical pearl is that early diagnosis and dietary restriction of phenylalanine can significantly improve outcomes in patients with hyperphenylalaninemia/PKU. Tetrahydrobiopterin (BH4) responsiveness is also an important consideration in some cases, as a subset of patients may benefit from BH4 supplementation.

## **Correct Answer:** **D.** phenylalanine hydroxylase